Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
Primary Purpose
Hypertension
Status
Completed
Phase
Phase 4
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Losartan 50mg/amlodipine 5mg
Losartan 100mg/amlodipine 5mg
Losartan 50mg/Hydrochlorothiazide 12.5mg
Losartan 100mg/Hydrochlorothiazide 25mg
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- Hypertension patients not included exclusion criteria
- Mean seated SBP ≥140mmHg in patients with newly Diagnosed
Exclusion Criteria:
- msDBP≥110mmHg or ms SBP ≥ 180mmHg at the screening and randomization visit
Sites / Locations
- Kyung Hee University Hospital at Gangdong
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Active Comparator
Active Comparator
Arm Label
Losartan 50mg/amlodipine 5mg
Losartan 100mg/amlodipine 5mg
Losartan50 mg/Hydrochlorothiazide12.5 mg
Losartan100 mg/Hydrochlorothiazide25 mg
Arm Description
Once daily, 1T, PO medication
Once daily, 1T, PO medication
Once daily, 1T, PO medication
Once daily, 1T, PO medication
Outcomes
Primary Outcome Measures
change from baseline in msSBP
Secondary Outcome Measures
change from baseline in AMcSBP
Full Information
NCT ID
NCT02294539
First Posted
November 12, 2014
Last Updated
March 14, 2017
Sponsor
Chong-Jin Kim
Collaborators
Hanmi Pharmaceutical Company Limited
1. Study Identification
Unique Protocol Identification Number
NCT02294539
Brief Title
Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
Official Title
Comparison of Effects Between Calcium Channel Blocker and Diuretics in Combination With Angiotensin II Receptor Blocker on 24-hr Central Blood Pressure and Vascular Hemodynamic Parameters in Hypertensive Patients Multicenter, Double-blind, Active-controlled, Phase 4 Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
August 2014 (undefined)
Primary Completion Date
May 18, 2016 (Actual)
Study Completion Date
May 18, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Chong-Jin Kim
Collaborators
Hanmi Pharmaceutical Company Limited
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to investigate which combination therapy is more effective for improving the blood pressure (BP) and AM central SBP in hypertensive patients:Angiotensin II receptor blocker (ARB) plus calcium channel blocker (CCB) or ARB plus diuretics
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
231 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Losartan 50mg/amlodipine 5mg
Arm Type
Experimental
Arm Description
Once daily, 1T, PO medication
Arm Title
Losartan 100mg/amlodipine 5mg
Arm Type
Experimental
Arm Description
Once daily, 1T, PO medication
Arm Title
Losartan50 mg/Hydrochlorothiazide12.5 mg
Arm Type
Active Comparator
Arm Description
Once daily, 1T, PO medication
Arm Title
Losartan100 mg/Hydrochlorothiazide25 mg
Arm Type
Active Comparator
Arm Description
Once daily, 1T, PO medication
Intervention Type
Drug
Intervention Name(s)
Losartan 50mg/amlodipine 5mg
Other Intervention Name(s)
amosartan 5/50mg
Intervention Description
once daily, 1T, PO medication
Intervention Type
Drug
Intervention Name(s)
Losartan 100mg/amlodipine 5mg
Other Intervention Name(s)
amosartan 5/100mg
Intervention Description
once daily, 1T, PO medication
Intervention Type
Drug
Intervention Name(s)
Losartan 50mg/Hydrochlorothiazide 12.5mg
Other Intervention Name(s)
Cozaar Plus
Intervention Description
once daily, 1T, PO medication
Intervention Type
Drug
Intervention Name(s)
Losartan 100mg/Hydrochlorothiazide 25mg
Other Intervention Name(s)
Cozaar Plus F
Intervention Description
once daily, 1T, PO medication
Primary Outcome Measure Information:
Title
change from baseline in msSBP
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
change from baseline in AMcSBP
Time Frame
20 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Hypertension patients not included exclusion criteria
Mean seated SBP ≥140mmHg in patients with newly Diagnosed
Exclusion Criteria:
- msDBP≥110mmHg or ms SBP ≥ 180mmHg at the screening and randomization visit
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chong-Jin Kim
Organizational Affiliation
Kyung Hee University Hospital at Gangdong
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kyung Hee University Hospital at Gangdong
City
Seoul
Country
Korea, Republic of
12. IPD Sharing Statement
Citations:
PubMed Identifier
31099387
Citation
Cho EJ, Lee HY, Sung KC, Park S, Sohn IS, Park CG, Choi DJ, Ha JW, Ahn YK, Shin J, Hong SJ, Kim SK, Chung WJ, Yoo BS, Hong TJ, Youn HJ, Cho MC, Chae SC, Kim YJ, Kim CJ. Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study. Am J Hypertens. 2019 Sep 24;32(10):992-1002. doi: 10.1093/ajh/hpz050.
Results Reference
derived
PubMed Identifier
28879040
Citation
Oh GC, Lee HY, Chung WJ, Youn HJ, Cho EJ, Sung KC, Chae SC, Yoo BS, Park CG, Hong SJ, Kim YK, Hong TJ, Choi DJ, Hyun MS, Ha JW, Kim YJ, Ahn Y, Cho MC, Kim SG, Shin J, Park S, Sohn IS, Kim CJ. Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial. Clin Hypertens. 2017 Sep 4;23:18. doi: 10.1186/s40885-017-0074-0. eCollection 2017.
Results Reference
derived
Learn more about this trial
Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
We'll reach out to this number within 24 hrs